SpringWorks Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
Well, terrific. Good afternoon, everybody, and welcome once again to the 4th Annual Oncology Innovation Summit. I'm Yaron Werber, one of the biotech analysts here at TD Cowen, and it's a great pleasure to moderate the next session with SpringWorks Therapeutics and Badreddin Edris, who is Chief Operating Officer. Badreddin, always good to see you. Thanks for joining us.
Likewise, Yaron. Thanks so much for hosting us.
So lots to talk about. And as always, if there's any questions, feel free to email them directly to me at [email protected]. Or you can log into the Wall Street Webcasting webpage here and go ahead and type your question, and I can definitely say it anonymously for you.
Questions & Answers
So I wanted to touch on, first of all, mirdametinib, lots going on with the ReNeu study now that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
